|
|
About Inverness Medical Innovations Australia and New
Zealand
Since 2001, Inverness Medical has focused on the development,
manufacture and marketing of advanced consumer and professional
medical diagnostic products. Through strategic acquisitions and the
effective use of a vast intellectual property portfolio, the
company now operates on a global scale providing locally relevant,
world-class diagnostic tests and services to customers in the
private, public and non-government organisational (NGO)
sectors.
Inverness Medical concentrates its efforts in five key areas:
infectious diseases, cardiology, women’s health, drugs of abuse and
oncology. The organisation owns numerous patented technologies for
both consumer and professional diagnostics, and offers an expanding
range of products that includes brands such as Clearview, Testpack,
Binax, Determine, and Biosite.
Inverness Medical is led by an experienced and committed
executive team dedicated to bringing to market new and innovative
products through breakthrough research and development. Strategic
acquisitions are particularly meaningful to the business, enabling
it to expand and diversify its range of offerings.
In January 2008, Inverness Medical acquired Panbio Limited − a
leading developer of tests used in the diagnosis of flaviviruses
and other arthropod-borne viruses. Panbio was first-to-market with
diagnostics for Ross River virus, West Nile virus, Japanese
Encephalitis and dengue fever and its range of technical platforms
includes enzyme-linked immmunosorbant assay (ELISA) and rapid
lateral flow technology. Panbio® now lives on as a premium
Australian brand of diagnostic products within the global Inverness
medical portfolio. The Panbio® range of dengue diagnostics leads
the world in dengue detection.
Today, Inverness medical is the world’s sixth largest, and
fastest growing, global in vitro diagnostics company. The
organisation has major research and development and manufacturing
facilities in North America, Europe, the Middle East and Asia
Pacific and global sales and distribution capabilities are also
undergoing rapid expansion.
With its global footprint and time-tested brands Inverness
Medical continues to maintain focus on locally relevant disease
areas ensuring that our customers have the tools for the diagnosis
and management of diseases and conditions.
|
|
|